Topical selinexor for diabetic foot ulcers

Phase 2, randomised trial in diabetic foot ulcer (DFU) comparing Selinexor gel + standard of care, Vehicle gel + standard of care and Standard of care alone (3 arms). Primary endpoint: Safety and tolerability of selinexor gel. Planned start Dec 2014; status: withdrawn.